Aplastic anemia secondary to nivolumab and ipilimumab in a patient with metastatic melanoma: a case report

BACKGROUND: Immune checkpoint blockade (ICB) is becoming an increasingly prevalent strategy in the clinical realm of cancer therapeutics. With more patients being administered ICB for a host of tumor types, the scope of adverse events associated with these drugs will likely grow. Here we report a ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyers, D. E., Hill, W. F., Suo, A., Jimenez-Zepeda, V., Cheng, T., Nixon, N. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859826/
https://www.ncbi.nlm.nih.gov/pubmed/29568696
http://dx.doi.org/10.1186/s40164-018-0098-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859826/
https://www.ncbi.nlm.nih.gov/pubmed/29568696
http://dx.doi.org/10.1186/s40164-018-0098-5

Ejemplares similares